A Change of Plans
I was very excited when I decided to participate in my first ultra marathon – the PRO:SPORT Ultra 50k race. I started running with a water pack and…
Positive Results for New Sanofi-aventis Type 2 Diabetes Drug
Sanofi-aventis announced that the GetGoal-X Phase 3 study of lixisenatide, a once-daily GLP-1 receptor agonist, has achieved primary efficacy endpoint. Lixisenatide, a glucagon-like peptide-1 agonist (GLP-1), is in development for the treatment of patients with type 2 diabetes mellitus.
Needle Goes In
I hadn’t found a sweet spot, the place where the needle to the insertion set goes into flesh like a knife into softened butter. Instead, the…
Neutralizing the Sugars
As I head to the lab for a blood test this morning for my endo appointment next week, I’m reminded of how I used to approach my three month blood test.…
Learning to Ride: A Riff
I’m pretty proud of myself, so please excuse me while I go ahead and share my adventure from this weekend: I took my first ride on the back of…
Diabetes My Way
Hi all! Just wanted to let you know that my blog at www.diabetesmyway.org will now be hosted by A Sweet Life, where other people with diabetes gather…